154 related articles for article (PubMed ID: 23769740)
1. A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells.
Guo M; Wang M; Deng H; Zhang X; Wang ZY
Eur J Pharmacol; 2013 Aug; 714(1-3):56-64. PubMed ID: 23769740
[TBL] [Abstract][Full Text] [Related]
2. Broussoflavonol B restricts growth of ER-negative breast cancer stem-like cells.
Guo M; Wang M; Zhang X; Deng H; Wang ZY
Anticancer Res; 2013 May; 33(5):1873-9. PubMed ID: 23645733
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells.
Pan X; Zhao B; Song Z; Han S; Wang M
J Pharmacol Sci; 2016 Feb; 130(2):85-93. PubMed ID: 26810571
[TBL] [Abstract][Full Text] [Related]
4. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells.
Zhang XT; Kang LG; Ding L; Vranic S; Gatalica Z; Wang ZY
Oncogene; 2011 Feb; 30(7):770-80. PubMed ID: 20935677
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells.
Yin L; Zhang XT; Bian XW; Guo YM; Wang ZY
PLoS One; 2014; 9(9):e107369. PubMed ID: 25203051
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
[TBL] [Abstract][Full Text] [Related]
7. Characteristic Binding Landscape of Estrogen Receptor-α36 Protein Enhances Promising Cancer Drug Design.
Adewumi AT; Mosebi S
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136668
[TBL] [Abstract][Full Text] [Related]
8. Broussoflavonol B from
Jeong JH; Ryu JH
Molecules; 2020 May; 25(10):. PubMed ID: 32429421
[TBL] [Abstract][Full Text] [Related]
9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
10. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
Lee EJ; Oh SY; Sung MK
Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.
Zhang X; Ding L; Kang L; Wang ZY
PLoS One; 2012; 7(1):e30174. PubMed ID: 22276155
[TBL] [Abstract][Full Text] [Related]
12. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
[TBL] [Abstract][Full Text] [Related]
13. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.
Guo Y; Zhang X; Meng J; Wang ZY
Eur J Pharmacol; 2011 May; 658(2-3):114-22. PubMed ID: 21376032
[TBL] [Abstract][Full Text] [Related]
14. Non-Benzoquinone Geldanamycin Analog, WK-88-1, Induces Apoptosis in Human Breast Cancer Cell Lines.
Zhao YR; Li HM; Zhu M; Li J; Ma T; Huo Q; Hong YS; Wu CZ
J Microbiol Biotechnol; 2018 Apr; 28(4):542-550. PubMed ID: 29618179
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.
Santha S; Bommareddy A; Rule B; Guillermo R; Kaushik RS; Young A; Dwivedi C
PLoS One; 2013; 8(2):e56982. PubMed ID: 23451128
[TBL] [Abstract][Full Text] [Related]
16. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
17. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells.
Zhang X; Deng H; Wang ZY
J Steroid Biochem Mol Biol; 2014 Sep; 143():434-43. PubMed ID: 24973581
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.
Zhang X; Wang ZY
Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.
Pledgie-Tracy A; Sobolewski MD; Davidson NE
Mol Cancer Ther; 2007 Mar; 6(3):1013-21. PubMed ID: 17339367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
